Ocular effects of topical and systemic steroids

Area of Science:

• Ophthalmology
• Endocrinology
• Pharmacology

Background:

• Systemic and topical steroids are widely used for various conditions.
• Steroid therapy can lead to significant complications, particularly ocular.
• Risk factors for steroid-induced complications must be identified before treatment.

Framework:

• Pre-treatment assessment should include patient history for conditions like cataracts, glaucoma, hypertension, diabetes, and infections.
• Baseline measurements such as blood pressure and tuberculin skin tests are recommended before long-term systemic steroid use.
• Routine monitoring during therapy may involve weight, blood pressure, electrolytes, blood sugar, and stool guaiac testing.

Implementation:

• Regular ophthalmologic screening is essential to prevent ocular complications.
• Cataract screening via slit-lamp examination is recommended 2-4 times annually based on steroid regimen.
• Glaucoma screening involves baseline and periodic intraocular pressure measurements, especially with topical or periocular steroid use.

Implications:

• Gradual tapering of topical ocular steroids prevents rebound inflammation.
• Prompt ophthalmologic evaluation is necessary for patients experiencing ocular discharge, pain, photophobia, or redness.
• Proactive management and monitoring can mitigate the risks associated with steroid therapy.